Radiologist Performance and Reliability of MR Scoring Systems in Perianal Fistulizing Crohn’s Disease: Retrospective Analysis in a Real-World Clinical Practice
Abstract Background Perianal fistulizing Crohn’s disease (CD-PAF) is difficult to treat, and several MR scoring systems have been developed to assess treatment response.Objective To assess the relationship between CD-PAF MR scoring systems and radiologists’ subjective assessment of CD-PAF severity and treatment response on baseline and follow-up pelvic MR.Methods Retrospective single institution study of consecutive symptomatic patients with CD-PAF patients who underwent pelvic MR before and ≥3 months after initiating biologic therapy during a 10-year period (December 2011 to December 2021). One of four radiologists interpreted baseline and follow-up MRs. Scoring systems included variables in the modified Van Assche index (mVAI), magnetic resonance novel index for fistula imaging in CD (MAGNIFI-CD), and pediatric MR-based perianal Crohn’s disease (PEMPAC) index. For initial and follow-up MR, a 5-point Likert scale assessed severity (1=mild, 3=moderate, 5=marked). On follow-up MR, radiologists evaluated fistula response as 1-improved, 3-stable, or 5-worsened CD-PAF severity. All four study radiologists scored the baseline MR in 20 patients to calculate inter-reader agreement statistics. Interrater reliability was assessed with the Krippendorff α coefficient for categorical variables and intraclass correlation coefficient (ICC) for continuous variables.Results The final cohort included 96 CD-PAF patients (50 men; mean age=33.0 years) with 192 baseline and follow-up MRs. Moderate to substantial agreement was observed among radiologists for MAGNIFI-CD, mVAI, PEMPAC, and Likert scores (ICC: 0.716, 0.756, 0.535, and 0.679 respectively). Individual components of MR scoring systems had Fair to Substantial agreement (Alpha: 0.195 to 0.730). Significant univariate associations were found between MR scoring systems and radiologists’ Likert severity assessments (p<0.001, Pearson correlation coefficients ≥0.820). In patients meeting criteria for change in disease severity (n=17), all scoring systems demonstrated AUC values ≥0.93.Conclusion The MR scoring systems for CD-PAF (MAGNIFI-CD, mVAI, and PEMPAC) demonstrated strong associations with radiologists’ subjective assessments of severity and treatment response on baseline and follow-up pelvic MR. Inter-reader agreement of these scoring systems outperformed individual MR factors..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
bioRxiv.org - (2023) vom: 12. Okt. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Abushamma, Suha [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.1101/2023.10.07.23296649 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI041102029 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI041102029 | ||
| 003 | DE-627 | ||
| 005 | 20231205144005.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231010s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2023.10.07.23296649 |2 doi | |
| 035 | |a (DE-627)XBI041102029 | ||
| 035 | |a (biorXiv)10.1101/2023.10.07.23296649 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Abushamma, Suha |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Radiologist Performance and Reliability of MR Scoring Systems in Perianal Fistulizing Crohn’s Disease: Retrospective Analysis in a Real-World Clinical Practice |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Background Perianal fistulizing Crohn’s disease (CD-PAF) is difficult to treat, and several MR scoring systems have been developed to assess treatment response.Objective To assess the relationship between CD-PAF MR scoring systems and radiologists’ subjective assessment of CD-PAF severity and treatment response on baseline and follow-up pelvic MR.Methods Retrospective single institution study of consecutive symptomatic patients with CD-PAF patients who underwent pelvic MR before and ≥3 months after initiating biologic therapy during a 10-year period (December 2011 to December 2021). One of four radiologists interpreted baseline and follow-up MRs. Scoring systems included variables in the modified Van Assche index (mVAI), magnetic resonance novel index for fistula imaging in CD (MAGNIFI-CD), and pediatric MR-based perianal Crohn’s disease (PEMPAC) index. For initial and follow-up MR, a 5-point Likert scale assessed severity (1=mild, 3=moderate, 5=marked). On follow-up MR, radiologists evaluated fistula response as 1-improved, 3-stable, or 5-worsened CD-PAF severity. All four study radiologists scored the baseline MR in 20 patients to calculate inter-reader agreement statistics. Interrater reliability was assessed with the Krippendorff α coefficient for categorical variables and intraclass correlation coefficient (ICC) for continuous variables.Results The final cohort included 96 CD-PAF patients (50 men; mean age=33.0 years) with 192 baseline and follow-up MRs. Moderate to substantial agreement was observed among radiologists for MAGNIFI-CD, mVAI, PEMPAC, and Likert scores (ICC: 0.716, 0.756, 0.535, and 0.679 respectively). Individual components of MR scoring systems had Fair to Substantial agreement (Alpha: 0.195 to 0.730). Significant univariate associations were found between MR scoring systems and radiologists’ Likert severity assessments (p<0.001, Pearson correlation coefficients ≥0.820). In patients meeting criteria for change in disease severity (n=17), all scoring systems demonstrated AUC values ≥0.93.Conclusion The MR scoring systems for CD-PAF (MAGNIFI-CD, mVAI, and PEMPAC) demonstrated strong associations with radiologists’ subjective assessments of severity and treatment response on baseline and follow-up pelvic MR. Inter-reader agreement of these scoring systems outperformed individual MR factors. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Balakrishna, Ravella |4 aut | |
| 700 | 1 | |a George, Alvin |4 aut | |
| 700 | 1 | |a Hickman, John |4 aut | |
| 700 | 1 | |a Ludwig, Daniel R. |4 aut | |
| 700 | 1 | |a Shetty, Anup S. |4 aut | |
| 700 | 1 | |a Zulfiqar, Maria |4 aut | |
| 700 | 1 | |a Ganapathy, Aravinda |4 aut | |
| 700 | 1 | |a Bishop, Grace |4 aut | |
| 700 | 1 | |a Elumalai, Anusha |4 aut | |
| 700 | 1 | |a Arora, Jyoti |4 aut | |
| 700 | 1 | |a Miller, Philip |4 aut | |
| 700 | 1 | |a Deepak, Parakkal |4 aut | |
| 700 | 1 | |a Ballard, David H. |0 (orcid)0000-0001-7470-3364 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2023) vom: 12. Okt. |
| 773 | 1 | 8 | |g year:2023 |g day:12 |g month:10 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2023.10.07.23296649 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 12 |c 10 | ||